Related by context. All words. (Click for frequent words.) 78 CD4 counts 75 CD4 + cell 73 median CD4 72 CD4 count 72 baseline CD4 71 viral load 69 CD4 69 CD4 + 68 CD4 cells 67 CD4 + T 66 CD4 T 66 viral loads 66 virologic failure 65 nadir CD4 cell 65 HAART 64 HIV RNA 64 antiretroviral therapy 63 cART 63 cells/mm3 62 undetectable viral load 60 viral suppression 60 HCV RNA 59 sustained virologic response 59 HbA1c levels 58 virologic response 58 copies ml 58 antiretroviral naïve 58 neutrophil count 58 eGFR 58 cells μL 58 serum testosterone 57 neutrophil counts 57 baseline CD4 + 57 platelet counts 57 antiretroviral therapy ART 57 serum creatinine levels 57 seroconversion 57 virological failure 57 serum HBV DNA 57 CD4 + cells 57 lymphocyte count 57 HBV DNA 57 copies mL 57 leukocyte count 56 hemoglobin concentrations 56 disease progression 56 homocysteine levels 56 serum vitamin D 56 cells mcL 56 sustained virological response 56 renal function 56 antiretroviral naive 55 undetectable HCV RNA 55 virologic suppression 55 HBV DNA levels 55 lymphocyte counts 55 PSADT 55 undetectable viral loads 55 viremia 55 serum PSA 55 serum creatinine 55 virologic responses 55 virological response 55 serum sodium 55 HIV infection 55 antibody titer 55 APTIVUS r 55 absolute lymphocyte 55 potent antiretroviral therapy 55 atazanavir 54 vicriviroc 54 HAART regimen 54 serum potassium 54 serum calcium 54 ng dL 54 HBeAg seroconversion 54 HIV infected 54 serum phosphate 54 CD4 lymphocyte count 54 nelfinavir 54 peginterferon 54 serum calcium levels 54 specific antigen PSA 54 Hb A1C 54 serum ALT 54 platelet reactivity 54 hemoglobin concentration 54 urate levels 54 virological suppression 54 LVEF 54 serum HCV RNA 54 granulocyte 54 antibody titers 54 raltegravir 53 darunavir 53 LEXIVA r 53 enfuvirtide 53 CD4s 53 HbA1c 53 HCV infected 53 virologic 53 fasting glucose levels 53 μmol L 53 troponin T 53 creatinine levels 53 systolic dysfunction 53 NNRTI 53 severe neutropenia 53 HAART regimens 53 RBC folate 53 hydroxyvitamin D levels 53 serum prostate 53 CD# + [002] 53 leukocytosis 53 IU mL 53 insulin detemir 53 PSA nadir 53 plasma folate 53 fasting blood glucose 53 lactate dehydrogenase LDH 53 A1C levels 53 tipranavir 53 cubic millimeter 52 antiretroviral regimen 52 plasma leptin 52 mg/m2 dose 52 biochemical recurrence 52 platelet count 52 ritonavir boosted 52 mm ³ 52 cells uL 52 HCV genotype 52 trastuzumab 52 serum urate levels 52 serum urate 52 genotypic resistance 52 HBeAg negative 52 cobicistat 52 lopinavir 52 liver histology 52 NNRTIs 52 CD# upregulation 52 coinfected 52 HbA1C 52 A1c levels 52 baseline LDH 52 TDF FTC 52 atazanavir ritonavir 52 virologically 52 plasma uric acid 52 estimated glomerular filtration 52 anti HBs 52 Kaplan Meier analysis 52 ARV therapy 52 HIV HCV coinfected 52 albumin excretion 52 Viral load 52 Hb levels 52 active antiretroviral therapy 52 homocysteine concentrations 52 HbA 1c levels 52 lymphocytosis 52 tipranavir ritonavir 52 KRAS mutations 52 mL/min/#.# m 2 52 plasma HCV RNA 52 antiretroviral treatment 52 serum IGF 52 lamivudine 52 saquinavir 52 telomere lengths 52 alanine aminotransferase ALT 52 HbA 1c 52 antihypertensive medications 52 peg interferon 51 experienced virologic failure 51 adalimumab 51 baseline HbA1c 51 hemoglobin Hb 51 serum concentrations 51 fasting glucose 51 serum clusterin levels 51 creatinine clearance 51 hemoglobin A1c levels 51 Antiretroviral Therapy 51 IGFBP 51 log# copies mL 51 fosamprenavir 51 adefovir 51 lopinavir r 51 pCR 51 alanine aminotransferase 51 anemia hemoglobin 51 HAQ DI 51 undetectable HBV DNA 51 NRTIs 51 d4T 51 ribavirin 51 glycated hemoglobin HbA1c 51 coinfected patients 51 glomerular filtration rate 51 undetectable viral 51 prostate specific 51 serum uric acid 51 lumbar spine BMD 51 QTcF 51 abacavir lamivudine 51 rapid virologic response 51 serum potassium levels 51 blood glucose concentrations 51 virologic response EVR 51 aminotransferases 51 serum folate 51 umol L 51 HIV seroconversion 51 adiponectin levels 51 paricalcitol 51 mg dL 51 lipid lowering therapy 51 pg ml 51 detectable HCV RNA 51 fasting plasma glucose 51 fasting insulin 51 serum LDL cholesterol 51 reach statistical significance 51 glycated hemoglobin levels 51 gout flares 51 microliter 51 serum phosphorus 51 HBsAg 51 Prostate Specific Antigen PSA 50 prospectively defined 50 monotherapy 50 ribavirin therapy 50 posttransplant 50 -#.# log# 50 progression TTP 50 thyroid stimulating hormone 50 virological 50 telomere length 50 microlitre 50 baseline A1C 50 #.#ng/ml 50 antiviral therapy 50 triglyceride concentrations 50 lipid lowering drugs 50 serum phosphate levels 50 biochemical relapse 50 triglyceride levels 50 nonfasting triglyceride levels 50 titers 50 resected pancreatic cancer 50 clodronate 50 serum glucose 50 DAS# [002] 50 seroprotection 50 serum albumin 50 estimated GFR 50 nonnucleoside reverse transcriptase inhibitors 50 PREZISTA r 50 ng mL 50 ABC/3TC 50 AZT zidovudine Retrovir 50 inflammatory biomarkers 50 folate supplementation 50 treatment naļve 50 mg kg dose 50 decitabine 50 transgene expression 50 HOMA IR 50 hsCRP levels 50 endometrial thickness 50 transaminase levels 50 telomerase activity 50 serum estradiol 50 mitoxantrone 50 HBeAg 50 mRCC 50 iPTH 50 SHBG levels 50 CMV infection 50 MELD score 50 glycemia 50 LV dysfunction 50 hENT1 50 baseline neutrophil counts 50 HER2 expression 50 aspartate aminotransferase AST 50 μg dose 50 plasma concentrations 50 hemoglobin levels 50 antiretroviral ARV therapy 50 protease inhibitor PI 50 Hb 50 mcg dose 50 beta blocker therapy 50 dose cohort 50 remission CR 50 MetS 50 NNRTI resistance 50 HBeAg positive 50 leukocyte counts 50 recurrent genital herpes 50 univariate analysis 50 thyrotropin levels 50 Free Survival PFS 50 proteinuria 50 glycosylated hemoglobin HbA1c 50 APTIVUS 50 viraemia 50 paraprotein 50 protease inhibitor 50 pegylated interferon 50 CHD mortality 50 dapagliflozin plus 49 lipoatrophy 49 Pegasys plus Copegus 49 PASI scores 49 annualized relapse 49 sunitinib 49 tertile 49 zoledronic acid 49 HSCT 49 CRp 49 elevated creatinine 49 anti retroviral therapy 49 seropositivity 49 doxorubicin docetaxel 49 dose ritonavir 49 rapid virological response 49 PSA velocity 49 tumor histology 49 neoadjuvant chemotherapy 49 advanced neoplasia 49 pyrazinamide 49 prostate specific antigen 49 plasma glucose 49 g dL 49 indinavir 49 androgen deprivation 49 PCa 49 genotype 49 mediated immunity 49 immune reconstitution 49 #mg QD [001] 49 CC genotype 49 boosted protease inhibitor 49 peg IFN 49 initiating HAART 49 viral kinetics 49 interferon 49 FOLFOX4 49 distant metastases 49 combination antiretroviral therapy 49 INTELENCE 49 EDSS score 49 coinfection 49 cardiovascular mortality 49 systolic BP 49 weekly subcutaneous injections 49 hemoglobin A1C 49 GnRH agonist 49 DMARD 49 antiretroviral 49 antigen PSA levels 49 Inhibin B 49 rituximab 49 systolic blood pressure 49 imatinib 49 BARACLUDE ® 49 tHcy 49 Virologic 49 recurrent VTE 49 multivariable analysis 49 Secondary efficacy endpoints 49 ng ml 49 DAPT 49 infliximab 49 adiponectin concentrations 49 BMD measurements 49 hydroxyurea 49 immunosuppression 49 locoregional 49 folate intake 49 serum PTH 49 nmol L 49 follicle stimulating hormone FSH 49 plasma viremia 49 IFN α 49 glycated hemoglobin 49 serum lipid levels 49 antiretroviral drugs 49 dose cyclophosphamide 49 leukopenia 49 CCR5 tropic HIV 49 HCV genotype 1 49 seropositive patients 49 REYATAZ r 49 blood Phe levels 49 microalbuminuria 49 Lp PLA2 49 nmol liter 49 hemoglobin A1c HbA1c 49 preoperative chemotherapy 49 mammographic density 49 pg mL 49 CCyR 49 tipranavir r 49 pmol L 49 dosage regimens 49 relapsed MM 49 metformin 49 log# reduction 49 cystatin C 49 HIV uninfected 49 insulin glargine 49 creatine kinase 49 bosentan 49 imatinib therapy 49 Retreatment 49 interferon ribavirin 49 peginterferon alfa 49 mg ustekinumab 49 heavily pretreated 49 overt hypothyroidism 49 nocturnal hypoglycaemia 48 MMSE score 48 colorectal neoplasia 48 Index CDAI 48 comparator PI r 48 anthracycline containing 48 hepatitis C genotype 48 anagrelide 48 CrCl 48 ritonavir boosted lopinavir 48 fasting triglyceride levels 48 prostate cancer CaP 48 T2DM 48 genotype 1b 48 Gag polymorphisms 48 d4T stavudine Zerit 48 blood glucose levels 48 Recurrence Score 48 dose dexamethasone 48 LPV r 48 sUA 48 ng dl 48 median PFS 48 ISENTRESS 48 evaluable subjects 48 chronic HCV infection 48 ALT flares 48 metabolic parameters 48 plasma pharmacokinetics 48 nephrotoxic drugs 48 ovarian carcinoma 48 LEXIVA 48 adenoma recurrence 48 basal cell nevus syndrome 48 azacitidine 48 IV bisphosphonates 48 #OHD levels 48 peginterferon alfa 2a 48 Insulin sensitivity 48 prospectively stratified 48 iPrEx study 48 eosinophil count 48 3TC lamivudine Epivir 48 metastatic lung cancer 48 hematologic toxicity 48 CIN3 48 antihypertensive therapy 48 daunorubicin 48 ERCC1 48 statistical significance p 48 serum antibody 48 low dose cytarabine 48 lymph node metastasis 48 definite stent thrombosis 48 atheroma volume 48 β blockers 48 NIHSS score 48 EpCAM expression 48 cisplatin chemotherapy 48 univariate analyzes 48 SUVmax 48 TT genotype 48 osteopenic 48 posaconazole 48 FEV1 48 prostate carcinoma 48 poorer prognosis 48 octreotide LAR 48 glycosylated hemoglobin levels 48 HBV infection 48 mEq L 48 thyroglobulin 48 entecavir 48 liver transplant recipients 48 lymphopenia 48 triple nucleoside 48 erythrocyte sedimentation rate 48 alteplase 48 prostate cancer CRPC 48 lopinavir ritonavir Kaletra 48 nucleoside naive 48 asymptomatic carotid stenosis 48 receiving antiretroviral therapy 48 postoperative mortality 48 intact parathyroid hormone 48 tamoxifen therapy 48 seroconverted 48 ritonavir 48 Multicenter AIDS 48 metastatic renal cell carcinoma 48 antigen PSA 48 MELD scores 48 vitamin D2 48 abacavir 48 hydroxyvitamin D 48 S#A# [002] 48 postmenopausal osteoporotic women 48 aspartate aminotransferase 48 % CI #.#-#.# [003] 48 mg dl 48 aciclovir 48 magnesium intake 48 subclinical hypothyroidism 48 CLL cells 48 dose cytarabine 48 HbA1C levels 48 steroid dexamethasone 48 RBC transfusions 48 MMSE scores 48 #mmHg [001] 48 hypogonadal 48 isolated systolic hypertension 48 pancreatic adenocarcinoma 48 mg BID 48 undetectable virus HCV 48 NPH insulin 48 Baseline characteristics 48 radioiodine therapy 48 CK MB 48 EDSS scores 48 IPAH 48 chlamydial infection 48 viral replication 48 Crohn Disease Activity 48 NRTI 48 CR nPR 48 advanced adenoma 48 complete cytogenetic response 48 ritonavir boosted protease inhibitor 48 P = .# 48 p = #.# [003] 48 hepatic fibrosis 48 CPAP adherence 48 testosterone supplementation 48 arterial thickening 48 PREZISTA rtv 48 lopinavir ritonavir 48 symptomatic intracerebral hemorrhage 48 mutated KRAS 48 LDL cholesterol levels 47 valacyclovir 47 glycosylated hemoglobin 47 concomitant medications 47 Natalizumab 47 moderate renal impairment 47 seroprevalence 47 Kaplan Meier curve 47 glargine 47 antioxidant supplementation 47 INCB# [001] 47 ibandronate 47 lactate dehydrogenase 47 adjuvant therapy 47 REYATAZ ® 47 methotrexate monotherapy 47 peginterferon alfa 2b 47 MADRS score 47 autoantibody levels 47 Therapy HAART 47 mycophenolate mofetil 47 pulmonary exacerbations 47 Stage IIIb 47 K#N 47 cotrimoxazole 47 Taxotere ® 47 placebo dexamethasone 47 CMV disease 47 stavudine 47 normotensive 47 clinico pathological 47 Naive Patients 47 urate lowering therapy 47 RBP4 47 renal dysfunction 47 Cmax 47 mucosal healing 47 pT3 47 VZV 47 NATRECOR ® 47 plasma homocysteine 47 β blocker 47 HBV infections 47 adjuvant chemotherapy 47 intramuscular dose 47 sUA levels 47 fructosamine 47 serum CRP 47 hepatic function 47 BRAF mutation 47 K ras mutations 47 chemo radiotherapy 47 euthyroid 47 metastatic RCC 47 postdischarge 47 antidiabetic medication 47 Virologic failure 47 azathioprine 47 topotecan 47 statin therapy 47 CsA 47 null responders 47 OADs 47 premenopausal 47 febrile neutropenia 47 elevated LDH 47 CD4 + lymphocytes 47 mIU L 47 ascending dose 47 Median survival 47 SHBG 47 left ventricular systolic 47 Elitek 47 URTI 47 ALT normalization 47 posttreatment 47 colorectal adenoma 47 fondaparinux 47 bone resorption 47 plasma glucose levels 47 placental malaria 47 adverse cytogenetics 47 smoldering multiple myeloma 47 NATRECOR R 47 reticulocytes 47 chronic HCV genotype 47 postoperative chemotherapy 47 superinfection 47 Median progression 47 HIV 47 periprocedural 47 Kaplan Meier 47 fragility fracture 47 serum IgE 47 intraocular pressure IOP 47 urine albumin 47 BENICAR HCT 47 operable breast cancer 47 intracranial hemorrhage ICH 47 gastric atrophy 47 SVR# 47 cTnT levels 47 genotypic 47 liver enzymes 47 nucleoside reverse transcriptase inhibitors 47 Serum creatinine 47 D dimer 47 CYP#D# genotype 47 LTBI 47 BCG vaccinated 47 highest tertile 47 EBRT 47 EGFR TKI 47 Cohort Study MACS 47 neutropenia 47 antibody responses 47 nucleotide analog 47 ejection fraction 47 HIVAN 47 serum testosterone levels 47 interferon therapy 47 chemosensitivity 47 serum aminotransferase levels 47 non squamous NSCLC 47 ABCB1 47 latent tuberculosis infection 47 nondepressed 47 eptifibatide 47 methotrexate therapy 47 Dose escalation 47 tolvaptan 47 advanced adenomas 47 Ad5 immunity 47 EGFR tyrosine kinase inhibitors 47 morphometric vertebral fractures 47 AZOR 47 calcitriol 47 NAbs 47 genotype 1a 47 elevated LDL cholesterol 47 HNSCC 47 creatinine 47 ejection fractions 47 latent TB infection 47 breast carcinoma 47 elevated CRP 47 postprandial glucose 47 KRAS mutant tumors 47 rilpivirine 47 Molecular Weight Heparin 47 co trimoxazole 47 elvitegravir 47 bezafibrate 47 glucocorticoid 47 EGFR mutation status 47 subtrochanteric 47 IV NSCLC 47 dosing cohorts 47 HIV tropism 47 EGFR mutations 47 mm3 47 T1DM 47 IFN gamma 47 bortezomib 47 multivariate Cox 47 docetaxel 47 A1c 47 fragility fractures 47 hours postdose 47 systolic pressure 47 NHANES III 47 pretransplant 47 hsCRP 47 aminotransferase levels 47 left ventricular ejection 47 REYATAZ r arm 47 spontaneous preterm birth 47 corticosteroid dose 47 neurocognitive function 47 mcg BID 47 REYATAZ 47 Vacc 4x 47 antiretroviral medications 47 carotid IMT 47 tuberculin skin testing 47 macroalbuminuria 46 selenium supplementation 46 gastric carcinoma 46 tiotropium 46 transferrin saturation 46 pioglitazone 46 epithelial ovarian cancer 46 mg/m2 46 ± SD 46 B7 H3 46 urinary albumin excretion 46 Kaplan Meier method 46 rhGH 46 AST ALT 46 timepoint 46 chronic HCV 46 RLAI 46 dose escalation phase 46 serum cortisol 46 tumor recurrence 46 #mg/m# [002] 46 hip BMD 46 angiotensin converting enzyme ACE 46 telomeres shorten 46 CVD mortality 46 pegylated interferon alpha 46 statistically significant p = 46 ddI 46 nitazoxanide 46 Telintra 46 serum phosphorous 46 abdominal adiposity 46 Bcl xL 46 serum magnesium 46 cortisol levels 46 Primary endpoints 46 zidovudine lamivudine 46 antiretrovirals 46 cortisol concentrations 46 microalbumin test 46 atherogenic dyslipidemia 46 pegylated interferon alfa 2b 46 darunavir ritonavir 46 efavirenz 46 PREZISTA ritonavir 46 free survival PFS 46 achieved ACR# 46 antiangiogenic therapy 46 NT proBNP 46 fasting plasma glucose FPG 46 PCA3 scores 46 candesartan 46 spontaneous preterm delivery 46 log# 46 HCV 46 serum folate concentrations 46 elevated transaminases 46 hormonal therapy 46 nevirapine Viramune 46 HBeAg negative patients 46 mmol l 46 #.#mmol L [002] 46 fetuin 46 bladder carcinoma 46 mg dose 46 poor metabolizers 46 pneumococcal vaccination 46 Virological 46 virologically suppressed 46 G CSF 46 radiographic progression 46 CD4 + CD# 46 #mg ATC 46 Rectal cancer 46 maraviroc 46 A1C 46 anti TNF 46 renal impairment 46 miR #a [001] 46 MS relapses 46 Doxil ® 46 Aptivus ® 46 unboosted 46 tenofovir 46 FOXP3 46 prior chemotherapy regimens 46 rimonabant #mg 46 BEACOPP 46 IL#B 46 relapsed AML 46 preoperative PSA 46 Hydroxyurea 46 argatroban 46 mmHg systolic 46 NRTI backbone 46 serum ferritin 46 mcg Albuferon 46 Sustained virologic response 46 nondiabetics 46 pharmacologic intervention 46 mCi m 2 46 concentration Cmax 46 HCV Genotype 46 Pred Forte 46 GnRH agonists 46 lipid lowering medications 46 ziprasidone 46 non progressors 46 advanced NSCLC 46 plasma cortisol 46 hypogonadal men 46 CD8 T cell 46 lipid elevations 46 HBeAg negative chronic hepatitis 46 colorectal carcinoma 46 FluCAM 46 anti leukemic 46 serum homocysteine 46 sociodemographic factors 46 ACR# responses 46 FOLFOX6 46 FOLPI 46 aged ≥ 46 #mg q8h 46 T1a 46 PHPT 46 EGFR expression 46 oral glucose tolerance 46 interferon alpha 46 liver enzymes ALT 46 intima media thickness 46 cubic milliliter 46 dose regimen 46 diastolic BP 46 integrase inhibitor 46 antihypertensive drugs 46 intermittent dosing 46 pyridostigmine 46 valopicitabine 46 TPV r 46 certolizumab 46 tenofovir emtricitabine 46 HER2 overexpression 46 gp# [001] 46 GVAX 46 blood Phe 46 trastuzumab Herceptin ® 46 Viral Load 46 % CI #.#-#.# [006] 46 urinary N telopeptide 46 BRCA mutation 46 clozapine 46 oral antidiabetic medication 46 Hgb 46 dalteparin 46 conditional logistic regression 46 Monotherapy 46 IELT 46 atazanavir sulfate 46 statistically nonsignificant 46 dehydroepiandrosterone sulfate 46 folate concentrations 46 saquinavir ritonavir 46 Folfox 46 serum TSH 46 SIV infection 46 seminoma 46 COMBIVIR 46 Index CDAI score 46 creatinine ratio 46 6MWD 46 interquartile range 46 p = .# [002] 46 PDE7B 46 unfractionated heparin 46 myelodysplastic syndromes MDS 46 BCIRG 46 triacylglycerol 46 sulfadoxine pyrimethamine 46 rFSH 46 lung function 46 PAOD 46 dose cohorts 46 histologic subtype 46 stage IIIb IV 46 Median PFS 46 Solid Tumors criteria 46 rFVIIa 46 aldosterone antagonists 46 nilotinib 46 interferon alfa 2a 46 cabazitaxel 46 M#V mutation 46 elevated serum creatinine 46 neurologic progression 46 antiretroviral regimens 46 protease inhibitors PIs 46 nucleoside analogue 46 alkaline phosphatase 46 Myelosuppression 46 timepoints 46 #Gy 46 KRAS status 46 loop diuretics 46 alfa 2a 46 ergocalciferol 46 -#.# log# copies mL 46 castration resistant prostate cancer 46 CCL#L# 46 iniparib 46 HbF 46 etanercept 46 cytarabine daunorubicin 46 triacylglycerol concentrations 46 BEXXAR Therapeutic Regimen 46 low expressors 46 tertiles 46 clinically meaningful 46 gefitinib 46 lopinavir r arm 46 placebo fluoxetine 46 intravenous diuretics 46 plasma triglycerides 46 DermaVir Patch 46 glulisine 46 lipid profiles 46 NSCLC 46 FTC TDF 46 penetrance 46 cotrimoxazole prophylaxis 46 atherogenic lipids 45 androgen deficiency 45 CDAI 45 mRNA expression 45 R0 resection 45 statistically significant 45 aminotransferase ALT 45 taxotere 45 Triglyceride levels 45 hemoglobin 45 PLCO 45 atypical hyperplasia 45 androgen therapy 45 achieved sustained virological 45 plasma glucose concentrations 45 antiretroviral medication 45 aromatase inhibitor therapy 45 liver enzyme 45 pharmacodynamic effects 45 telomere shortening